Literature DB >> 20688286

An outbreak of coxsackievirus A16 infection: comparison with other enteroviruses in a preschool in Taipei.

Pei-Chieh Wu1, Li-Min Huang, Chuan-Liang Kao, Tsui-Yen Fan, Ai-Ling Cheng, Luan-Yin Chang.   

Abstract

BACKGROUND/
PURPOSE: The transmission rate of enteroviruses in young children remains unclear. Therefore, we carried out active surveillance in preschool children to investigate the transmission rate and clinical manifestation of enteroviruses.
METHODS: From September 2006 to December 2008, we monitored infectious diseases in children 2(-3 years of age) in a preschool in Taipei. If any child had a febrile illness or symptoms/signs of enteroviral infection [e.g. herpangina or hand-foot-and-mouth disease (HFMD)], we performed viral isolation and enterovirus polymerase chain reaction. VP1 sequencing was performed to define their serotypes. We also collected clinical data and analyzed transmission rates.
RESULTS: There were eight episodes of enterovirus infection during the study period. The serotypes included coxsackievirus A4 (CA4), CA2 and CA16. The transmission rates of CA4 and CA2 among children in same class were 26% and 35%, respectively. Between November 28 and December 12, 2008, 13/21 (61.9%) children contracted herpangina and/or HFMD. The average age was 2.82 (range, 2.43-3.39) years. CA16 was detected in 10/13 (76.9%) of the throat swabs by polymerase chain reaction VP1 genotyping. Compared with previous CA2 and CA4 outbreaks, CA16 had a significantly higher transmission rate (p = 0.035) and resulted in more cases of HFMD (p < 0.001). The transmission duration of coxsackie A viruses within the same class ranged from 12 to 40 days.
CONCLUSION: Compared with CA2 and CA4, CA16 infections resulted in more cases of HFMD and had significantly higher transmission rates in preschoolers. Copyright (c) 2010 Taiwan Society of Microbiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688286     DOI: 10.1016/S1684-1182(10)60043-6

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  13 in total

Review 1.  Is a multivalent hand, foot, and mouth disease vaccine feasible?

Authors:  Michel Klein; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015-05-26       Impact factor: 3.452

2.  Association of interleukin-6-572C/G gene polymorphism and serum or cerebrospinal fluid interleukin-6 level with enterovirus 71 encephalitis in Chinese Han patients with hand, foot, and mouth disease.

Authors:  Aiyun Yuan; Jian Li; Peipei Liu; Zongbo Chen; Mei Hou; Jinju Wang; Zhenliang Han
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

3.  A neonatal mouse model of coxsackievirus A16 for vaccine evaluation.

Authors:  Qunying Mao; Yiping Wang; Rong Gao; Jie Shao; Xin Yao; Shuhui Lang; Chao Wang; Panyong Mao; Zhenglun Liang; Junzhi Wang
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

4.  Association of interleukin-17F gene polymorphism with enterovirus 71 encephalitis in patients with hand, foot, and mouth disease.

Authors:  Tiegang Lv; Jian Li; Zhenliang Han; Zongbo Chen
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

5.  Validation and utilization of an internally controlled multiplex Real-time RT-PCR assay for simultaneous detection of enteroviruses and enterovirus A71 associated with hand foot and mouth disease.

Authors:  Tran Tan Thanh; Nguyen To Anh; Nguyen Thi Tham; Hoang Minh Tu Van; Saraswathy Sabanathan; Phan Tu Qui; Tran Thuy Ngan; Tran Thi My Van; Lam Anh Nguyet; Nguyen Thi Han Ny; Le Thi My Thanh; Ong Kien Chai; David Perera; Do Chau Viet; Truong Huu Khanh; Do Quang Ha; Ha Manh Tuan; Kum Thong Wong; Nguyen Thanh Hung; Nguyen Van Vinh Chau; Guy Thwaites; H Rogier van Doorn; Le Van Tan
Journal:  Virol J       Date:  2015-06-09       Impact factor: 4.099

6.  Outbreak of febrile illness caused by coxsackievirus A4 in a nursery school in Beijing, China.

Authors:  Jin-Song Li; Xiao-Gen Dong; Meng Qin; Zhi-Ping Xie; Han-Chun Gao; Jun-Yong Yang; Xiao-Xin Yang; Dan-Di Li; Jie Li; Zhao-Jun Duan
Journal:  Virol J       Date:  2015-06-18       Impact factor: 4.099

7.  Clinical features and phylogenetic analysis of Coxsackievirus A9 in Northern Taiwan in 2011.

Authors:  Yi-Chuan Huang; Ying-Hsia Chu; Ting-Yu Yen; Wen-Chan Huang; Li-Min Huang; Ai-Ling Cheng; Hurng-Yi Wang; Luan-Yin Chang
Journal:  BMC Infect Dis       Date:  2013-01-24       Impact factor: 3.090

8.  Genetic characterization of a Coxsackie A9 virus associated with aseptic meningitis in Alberta, Canada in 2010.

Authors:  Kanti Pabbaraju; Sallene Wong; Eve N Y Chan; Raymond Tellier
Journal:  Virol J       Date:  2013-03-22       Impact factor: 4.099

9.  Circulating HFMD-associated coxsackievirus A16 is genetically and phenotypically distinct from the prototype CV-A16.

Authors:  Wei Wei; Haoran Guo; Jingliang Li; Sangsang Ren; Zhenhong Wei; Wanguo Bao; Xiaoming Hu; Ke Zhao; Wenyan Zhang; Yulai Zhou; Fei Sun; Richard Markham; Xiao-Fang Yu
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

10.  Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates.

Authors:  Jingliang Li; Junliang Chang; Xin Liu; Jiaxin Yang; Haoran Guo; Wei Wei; Wenyan Zhang; Xiao-Fang Yu
Journal:  J Gen Virol       Date:  2014-02-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.